Boehringer Ingelheim provides three €25,000 grants to fund independent research projects that generate new and practical information to allow a better understanding of this devastating swine disease PRRS (Porcine Reproductive and Respiratory Syndrome).
The three winning projects were chosen out of more than 20 high quality proposals coming from all across Europe, with topics that covered a wide variety of problems related to PRRS. The independent review board selected the following projects for this year’ award:
- Interference of Maternally Derived Antibodies with PRRS Vaccine in Piglets: Impact on Viral Parameters and Transmission (Olivier Bourry and Nicolas Rose, Anses - French Agency for Food, Environmental and Occupational Health and Safety, France)
- PRRSons Project (Carlos Piñeiro Noguera, PigCHAMP Pro Europa S.L., Spain)
- Alternative Sampling Methods in newborn Piglets for PRRS Diagnosis (Gerard E. Martín Valls, IRTA Campus de la Universitat Autònoma de Barcelona, Spain)
Swine scientists and experts from Europe and also the US participated in the award ceremony, which took place in the Boehringer Ingelheim headquarters in Ingelheim, Germany.
With the European PRRS Research Award Boehringer Ingelheim reinforces its commitment to support applied research for the improved control of PRRS in Europe and in the rest of the world. Including the three research awards for this year, and the 40 separate PRRS research projects awarded so far in the US, the company has contributed more than 1 million Euros in total.